Celltrion USA
Celltrion USA
1 Evertrust Plaza, Suite 1207,
Jersey City, NJ, 07302
Phone: 1-800-560-9414Website: https://www.celltrionusa.com/Careers: www.celltrionusa.com/board/recruitinglist
Latest news
- FDA Grants Interchangeable Designation to Yuflyma (adalimumab-aaty), Celltrion's Biosimilar to Humira (adalimumab)
14 April 2025 - FDA Approves Omlyclo (omalizumab-igec), an Interchangeable Biosimilar to Xolair
7 March 2025 - FDA Approves Osenvelt (denosumab-bmwo), a Biosimilar to Xgeva
3 March 2025 - FDA Approves Stoboclo (denosumab-bmwo), a Biosimilar to Prolia
3 March 2025 - FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar to Actemra
30 January 2025 - FDA Approves Steqeyma (ustekinumab-stba), a Biosimilar to Stelara
17 December 2024 - Zymfentra demonstrated long-term efficacy and safety profile of maintenance treatment for adults with moderately to severely active Crohn's disease and ulcerative colitis
21 May 2024 - Celltrion USA Completes Submission of Biologics License Application (BLA) to U.S. FDA for CT-P39, an Interchangeable Biosimilar Candidate of Xolair
10 March 2024 - FDA Approves Zymfentra (infliximab-dyyb) Subcutaneous Formulation for the Treatment of People With Inflammatory Bowel Disease
23 October 2023 - FDA Approves Yuflyma (adalimumab-aaty), a Biosimilar to Humira
24 May 2023
Drugs Associated with Celltrion USA
Celltrion USA manufactures, markets and/or distributes more than 17 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Avtozma
Generic name: tocilizumab Drug class: interleukin inhibitors |
||
|
famotidine
Generic Drug class: H2 antagonists |
164 reviews | 4.4 / 10 |
|
Herzuma
Generic name: trastuzumab Drug class: HER2 inhibitors |
||
|
Inflectra
Generic name: infliximab Drug class: TNF alfa inhibitors |
31 reviews | 4.0 / 10 |
|
levofloxacin
Generic Drug class: quinolones and fluoroquinolones |
672 reviews | 5.2 / 10 |
|
memantine
Generic Drug class: miscellaneous central nervous system agents |
91 reviews | 6.3 / 10 |
|
Omlyclo
Generic name: omalizumab Drug class: selective immunosuppressants |
||
|
Osenvelt
Generic name: denosumab Drug class: miscellaneous bone resorption inhibitors |
||
|
pioglitazone
Generic Drug class: thiazolidinediones |
45 reviews | 4.5 / 10 |
|
risperidone
Generic Drug class: atypical antipsychotics |
688 reviews | 5.5 / 10 |
|
Steqeyma
Generic name: ustekinumab Drug class: interleukin inhibitors |
||
|
Stoboclo
Generic name: denosumab Drug class: miscellaneous bone resorption inhibitors |
||
|
Temixys
Generic name: lamivudine/tenofovir disoproxil Drug class: antiviral combinations |
||
|
Truxima
Generic name: rituximab Drug class: CD20 monoclonal antibodies |
2 reviews | 9.0 / 10 |
|
Vegzelma
Generic name: bevacizumab Drug class: VEGF/VEGFR inhibitors |
||
|
Yuflyma
Generic name: adalimumab Drug class: TNF alfa inhibitors |
1 review | 8.0 / 10 |
|
Zymfentra
Generic name: infliximab Drug class: TNF alfa inhibitors |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||